Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Maher

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Toxicology and Applied Pharmacology|February 4, 2010
The rise of antioxidant signaling--the evolution and hormetic actions of Nrf2Jonathan Maher, Masayuki Yamamoto
Cancer Research|December 24, 2010
Select heterozygous Keap1 mutations have a dominant-negative effect on wild-type Keap1 in vivoTakafumi Suzuki, Jonathan Maher, Masayuki Yamamoto
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 21, 2019
Predicting Human Infection Risk: Do Rodent Host Resistance Models Add Value?Kai Connie Wu, Yu Zhong, Jonathan Maher
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2005
Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps)Xingguo Cheng, Jonathan Maher, Chuan Chen, et al.
Molecular Pharmacology|June 30, 2006
Endocrine regulation of gender-divergent mouse organic anion-transporting polypeptide (Oatp) expressionXingguo Cheng, Jonathan Maher, Hong Lu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 28, 2005
Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathwaysXingguo Cheng, Jonathan Maher, Matthew Z Dieter, et al.
Toxicology and Applied Pharmacology|April 4, 2022
Establishment of baseline profiles of 50 bile acids in preclinical toxicity species: A comprehensive assessment of translational differences and study design considerations for biomarker developmentDewakar Sangaraju, Paula Katavolos, Xiaorong Liang, et al.
Journal of Applied Toxicology : JAT|November 13, 2013
Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitisJohn D Clarke, Tatiana Sharapova, April D Lake, et al.
Chemical Research in Toxicology|December 2, 2015
Safety Lead Optimization and Candidate Identification: Integrating New Technologies into Decision-MakingDonna M Dambach, Dinah Misner, Mathew Brock, et al.
Archives of Toxicology|June 26, 2020
In vitro assessment of farnesoid X receptor antagonism to predict drug-induced liver injury riskLeah M Norona, Aaron Fullerton, Chris Lawson, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Toxicology and Applied Pharmacology|February 4, 2010
The rise of antioxidant signaling--the evolution and hormetic actions of Nrf2Jonathan Maher, Masayuki Yamamoto
Cancer Research|December 24, 2010
Select heterozygous Keap1 mutations have a dominant-negative effect on wild-type Keap1 in vivoTakafumi Suzuki, Jonathan Maher, Masayuki Yamamoto
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 21, 2019
Predicting Human Infection Risk: Do Rodent Host Resistance Models Add Value?Kai Connie Wu, Yu Zhong, Jonathan Maher
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2005
Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps)Xingguo Cheng, Jonathan Maher, Chuan Chen, et al.
Molecular Pharmacology|June 30, 2006
Endocrine regulation of gender-divergent mouse organic anion-transporting polypeptide (Oatp) expressionXingguo Cheng, Jonathan Maher, Hong Lu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 28, 2005
Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathwaysXingguo Cheng, Jonathan Maher, Matthew Z Dieter, et al.
Toxicology and Applied Pharmacology|April 4, 2022
Establishment of baseline profiles of 50 bile acids in preclinical toxicity species: A comprehensive assessment of translational differences and study design considerations for biomarker developmentDewakar Sangaraju, Paula Katavolos, Xiaorong Liang, et al.
Journal of Applied Toxicology : JAT|November 13, 2013
Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitisJohn D Clarke, Tatiana Sharapova, April D Lake, et al.
Chemical Research in Toxicology|December 2, 2015
Safety Lead Optimization and Candidate Identification: Integrating New Technologies into Decision-MakingDonna M Dambach, Dinah Misner, Mathew Brock, et al.
Archives of Toxicology|June 26, 2020
In vitro assessment of farnesoid X receptor antagonism to predict drug-induced liver injury riskLeah M Norona, Aaron Fullerton, Chris Lawson, et al.
Pageof 3